| News
Basel among the most future-oriented cities in Europe
18.02.2022
fDi Intelligence has investigated the most important tech cities across Europe. Basel secured top spot for cities up to 350'000 people. In terms of foreign direct investment strategies, the Basel Area was ranked in second place in regions category up to 1,5 Mio people.

Copyright. Basel Tourism
The competence center for foreign direct investment of the Financial Times, fDi Intelligence, has once again compared Europe’s future-oriented tech cities. In the ranking, Basel achieved the top position for European tech cities of the future, for cities with populations of between 100,000 and 350,000 people.
The city owes its top ranking above all to its economic potential. In the specific ranking for this aspect, Basel took second place across Europe. The city’s significant human capital and good quality of life saw it also ranked in fourth place for this category.
The ranking also highlighted that Basel is home to major pharma giants such as Roche, Novartis, and Roivant Sciences. However, the city also attracts investments in the area of professional services. Hence service providers were responsible for more than a quarter of new investments in Basel in the period between October 2016 and September 2021. In addition, the city’s key strategic position at the border between Switzerland, Germany, and France was highlighted.

European Cities and Regions of the Future 2022/23 (fDi Intelligence)
Furthermore, fDi Intelligence produced a ranking specifically for European regions. Here, the focus was primarily on strategies for attracting foreign direct investment. In the category of small regions, the Basel Area claimed second place in the overall European ranking.
Award Ceremony in Cannes
The fDi Intelligence awards remain valid for a period of two years. The award ceremony is set to take place in Cannes, France, on March 15.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read More